The federal suit filed in Massachusetts accuses drug makers Sanofi, Novo Nordisk and Eli Lilly of raising the list prices of their products “in perfect lock step” for years.
The accusations center on the shadowy rebate system between drug makers and pharmacy benefit managers, which this news outlet has been investigating.
Read more about the lawsuit: Insulin makers accused of price-fixing scheme
More from our investigation:
In Other News
1
Yellow Springs will ask voters to reconsider school levy after election...
2
More New Lebanon village staff fired for cause, weeks after being put...
3
Last-minute U.S. spending package fully funds Wright-Patt child...
4
Indian Lake State Park reopens today after tornado, storms
5
Lebanon approves use of automatic license plate readers
About the Author